As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY 9 LDP Leader Candidates Showcase Pharma Agendas in Campaign
September 17, 2024
-
BUSINESS Eisai Set on Streamlining Operations to Drive Drug Innovation: COO
September 13, 2024
-
ORGANIZATION Pharma Industry Prepares List of 68 Lawmakers to Support in Likely Snap Poll
September 12, 2024
-
REGULATORY Mounjaro to Keep Price after CEA as Lilly’s Appeal for Raise Nixed
September 12, 2024
-
REGULATORY AMED Research Exploring Low-Cost Method to Analyze Nitrosamine Impurities
September 11, 2024
-
COMMENTARY LLP Info Might Become Inaccessible If New Coverage Rule Speeds Up Exit
September 10, 2024
-
BUSINESS Mitsubishi Chemical Denies Media Report on Pharma Divestiture
September 9, 2024
-
REGULATORY MHLW to Accept English Dossiers from Foreign Makers
September 9, 2024
-
REGULATORY MOF Intent on Expanding Scope of Off-Year Revision in 2025: Budget Examiner
September 6, 2024
-
REGULATORY Japan Poised to Launch FIH Trial System in FY2029 to Attract Global Seeds
September 5, 2024
-
BUSINESS Kidswell Is Open to M&As Amid Challenging Financing Environment: CEO
September 4, 2024
-
BUSINESS BMS Aspires to Double Japan Sales over Next Decade with 5 Growth Drivers
September 3, 2024
-
BUSINESS Takeda Pushes Back Shipping Date as Trucker Overtime Cap Hits Logistics
September 2, 2024
-
BUSINESS AstraZeneca Japan Launches Research on Lung Cancer Survival Rate Using National Registry
August 30, 2024
-
REGULATORY MHLW to Seek Nearly 800 Million Yen to Boost New Modalities: FY2025 Budget Request
August 29, 2024
-
REGULATORY Japan Approves Label Expansions for Alecensa, Nucala and More
August 29, 2024
-
BUSINESS Regeneron to Hire 73 Rhinology Sales Reps to Back Dupixent Label Expansion
August 28, 2024
-
REGULATORY High-Dose Mecobalamin Now in Line to Become Japan’s 1st ALS Med in 9-Plus Years
August 28, 2024
-
ACADEMIA A Time for Patience - 5: Focus Turning to Early and Preclinical ALS Treatment, TDP-43 as New Target
August 28, 2024
-
BUSINESS A Time for Patience - 4: Toho University Joins Ionis’ Global Trial for FUS-ALS
August 27, 2024
ページ
A total of 43 innovative new medicines are anticipated to be approved or listed in Japan this year, according to a survey by Jiho. At the center of attention are some highly innovative, but probably ultra-expensive, gene therapies, as well…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…